Brief: Acurx Pharmaceuticals Reports Q3 2024 Results And Provides Business Update
13/11/2024 13:22
Nov 13 (Reuters) - Acurx Pharmaceuticals Inc ACXP.O :
* ACURX PHARMACEUTICALS, INC. REPORTS THIRD QUARTER 2024
RESULTS
AND PROVIDES BUSINESS UPDATE
* ACURX PHARMACEUTICALS INC: QTRLY LOSS PER SHARE $0.17
Source text: urn:newsml:reuters.com:*:nPn390Kj1a
Further company coverage: ACXP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Acurx Pharmaceuticals
See all newsBrief: Acurx Pharmaceuticals Receives FDA Conditional Acceptance
Acurx Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Acurx Pharmaceuticals Q2 loss widens on higher R&D costs
Acurx Pharmaceuticals Inc expected to post a loss of 38 cents a share - Earnings Preview
Brief: FDA Provides Further Regulatory Guidance To Acurx Pharmaceuticals For The Ibezapolstat Clinical Development Program